Showing results (281-290 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|August 19, 2021
Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral PotencyChun-Hui Zhang, Krasimir A Spasov, Raquel A Reilly, et al.
ACS Medicinal Chemistry Letters|August 20, 2021
Efficient NMR Screening Approach to Discover Small Molecule Fragments Binding Structured RNAMatthew D Shortridge, Gabriele Varani
ACS Medicinal Chemistry Letters|August 20, 2021
Discovery of TDI-10229: A Potent and Orally Bioavailable Inhibitor of Soluble Adenylyl Cyclase (sAC, ADCY10)Makoto Fushimi, Hannes Buck, Melanie Balbach, et al.
ACS Medicinal Chemistry Letters|August 20, 2021
Optimization of Naphthyridones into Selective TATA-Binding Protein Associated Factor 1 (TAF1) Bromodomain InhibitorsMichael A Clegg, Natalie H Theodoulou, Paul Bamborough, et al.
ACS Medicinal Chemistry Letters|August 20, 2021
Structure-Activity Relationship Studies Reveal New Astemizole Analogues Active against Plasmodium falciparum In VitroDickson Mambwe, Malkeet Kumar, Richard Ferger, et al.
ACS Medicinal Chemistry Letters|August 16, 2022
A Warhead Substitution Study on the Coronavirus Main Protease Inhibitor NirmatrelvirSubramanyam Vankadara, Monique Danielle Dawson, Jia Yi Fong, et al.
ACS Medicinal Chemistry Letters|August 18, 2022
N-Alkyl-2-Quinolonopyrones Demonstrate Antimicrobial Activity against ESKAPE Pathogens Including Staphylococcus aureusEoin Moynihan, Katrina Mackey, Mark A T Blaskovich, et al.
ACS Medicinal Chemistry Letters|August 18, 2022
Small-Molecule Inhibitors of the MLL1 CXXC Domain, an Epigenetic Reader of DNA MethylationHanuman P Kalmode, Izabella Podsiadly, Ashish Kabra, et al.
ACS Medicinal Chemistry Letters|August 18, 2022
Innovation Experiences from Africa-Led Drug Discovery at the Holistic Drug Discovery and Development (H3D) CentreVinayak Singh, Dickson Mambwe, Constance Mawunyo Korkor, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
Sulfonimide and Amide Derivatives as Novel PPARα Antagonists: Synthesis, Antiproliferative Activity, and Docking StudiesAlessandra Ammazzalorso, Isabella Bruno, Rosalba Florio, et al.
Pageof 438